Feasibility and efficacy of resistance training in cerebral palsy (CP)

Conditions

Topic: Children, Musculoskeletal disorders

Jennifer Ryan, Cherry Kilbride, Marika Noorkõiv, Nicola Theis, Adam Shortland et al. (7 authors)

Disability and Rehabilitation2023-05-081 citations

10.1080/09638288.2023.2208377

Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF) as a measure of physical activity (PA) in young people with cerebral palsy: A cross-sectional study.

Lavelle G, Noorkoiv M, Theis N, Korff T, Kilbride C, Baltzopoulos V, Shortland A, Levin W, Ryan JM.

2019-08-2232 citations

10.1016/j.physio.2019.08.013

Strength Training for Adolescents with cerebral palsy (STAR): study protocol of a randomised controlled trial to determine the feasibility, acceptability and efficacy of resistance training for adolescents with cerebral palsy

Jennifer Ryan, Nicola Theis, Cherry Kilbride, Vasilios Baltzopoulos, Charlotte Waugh et al. (10 authors)

BMJ Open2016-10-0124 citations

10.1136/bmjopen-2016-012839

Interventions

Progressive resistance training will be performed three times per week for 10 weeks

two sessions will be carried out at participants’ homes and one will be a group session carried out in participants’ local physiotherapy departments or gyms. Single-joint plantarflexor exercises will

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adolescents with cerebral palsy aged 10-19 years (amended from 12-19 years on 12/07/2016) 2. The ability to walk independently with or without a mobility aid 3. The ability to activate the ankle plantarflexors

Exclusion criteria

Exclusion criteria: 1. Orthopaedic surgery in the past year 2. Botulinum toxin type A (Botox) injections or serial casting in the past 6 months 3. Receiving intrathecal baclofen 4. Unable to comply with the protocol

Design outcomes

Primary

Measure	Time frame
Gait efficiency measured using indirect calorimetry at 0, 10 and 22 weeks	—

Secondary

Measure	Time frame
1. Physical activity measured using accelerometry 2. Participation measured using Assessment of Life Habits questionnaire (Life-H) 3. Gross Motor Function measured using components D and E of Gross Motor Function Measure (GMFM) and 10m walking trial 4. Muscle strength measured using isokinetic dynamometry 5. Muscle activity during dynamometry and treadmill walking measured using EMG 6. Muscle and tendon force measured using isokinetic dynamometry and ultrasonography 7. Muscle and tendon length measured using ultrasonography and motion analysis 8. Muscle and tendon stiffness measured using ultrasonography and motion analysis 9. Muscle, tendon and fascicle strain measured using ultrasonography 10. Muscle and tendon cross-sectional area measured using ultrasonography 11. Quality of life measured using EQ-5D-Y and CHU 9D All measured at 0, 10 and 22 weeks Deleted 04/08/2016: Movement quality measured using Quality Function Measure	—

Measure

Time frame

1. Physical activity measured using accelerometry 2. Participation measured using Assessment of Life Habits questionnaire (Life-H) 3. Gross Motor Function measured using components D and E of Gross Motor Function Measure (GMFM) and 10m walking trial 4. Muscle strength measured using isokinetic dynamometry 5. Muscle activity during dynamometry and treadmill walking measured using EMG 6. Muscle and tendon force measured using isokinetic dynamometry and ultrasonography 7. Muscle and tendon length measured using ultrasonography and motion analysis 8. Muscle and tendon stiffness measured using ultrasonography and motion analysis 9. Muscle, tendon and fascicle strain measured using ultrasonography 10. Muscle and tendon cross-sectional area measured using ultrasonography 11. Quality of life measured using EQ-5D-Y and CHU 9D All measured at 0, 10 and 22 weeks Deleted 04/08/2016: Movement quality measured using Quality Function Measure

—

Countries

England, United Kingdom

Outcome results

None listed